Dr. Nicholas Milano of Medical University of SC says medications such as Lecanemab and donanemab give Alzheimer's patients ...

Helicobacter pylori, best known for causing stomach ulcers, was shown to block the build-up of both amyloid-beta and tau in ...

TAIPEI (Taiwan News) — Far Eastern Memorial Hospital is set to become the first medical institution in Taiwan to administer ...

Her doctors had never seen a case of similarly massive bleeding. My report in Science on the death quickly became the subject of global headlines: The most promising anti-amyloid treatment was ...

In patients showing cognitive decline, a new blood test for Alzheimer's is expected to make diagnosis more convenient, ...

A third anti-amyloid, aducanumab (Aduhelm), was fast-tracked for approval in 2021, but the drugmaker took it off the market in early 2024 to focus on other drugs for Alzheimer’s.

That said, people shouldn’t start anti-amyloid treatment if they have certain medical conditions or are taking medications that boost their odds of serious bleeding. And remember that APOE e4 gene?

Anti-amyloid medications can help treat people in the early stages of Alzheimer’s by removing amyloid plaques from the brain. Although they’re not a cure for Alzheimer’s, they may help slow ...

In a real-world study, infusion-related reactions occurred in 37% of Alzheimer's patients treated with lecanemab. Amyloid-related imaging abnormalities (ARIA) emerged in 22% of treated patients ...

The 78-year-old woman experienced a brain bleed in her right front lobe, dying on day 44 of the study. Roche said a screening MRI demonstrated signs of cerebral amyloid angiopathy (CAA), a conditi ...

Drugs that slow progression of Alzheimer’s don’t provide enough benefit to justify substantial cost for NHS, regulator has ...